| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $136K | — | — |
| SG&A Expense | $650K | +2.6% | +151.7% |
| Operating Income | -$787K | -24.1% | -204.5% |
| Interest Expense | $23K | -3.7% | -91.5% |
| Income Tax | -$50 | +55.8% | — |
| Net Income | -$814K | -22.7% | -53.7% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12K | -93.2% | +3865.6% |
| Current Assets | $48K | -74.9% | +2539.2% |
| Total Assets | $618K | -19.1% | -2.4% |
| Current Liabilities | $4.9M | +1.5% | +1.5% |
| Total Liabilities | $5.3M | +0.1% | -1.4% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$997K | -108.7% | — |
| Investing Cash Flow | -$39K | — | — |
| Financing Cash Flow | $395K | — | — |
| -$4.7M |
| -3.3% |
| +1.2% |